Choi Jang-Gi, Jin Young-Hee, Kim Ji-Hye, Oh Tae Woo, Yim Nam-Hui, Cho Won-Kyung, Ma Jin Yeul
Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine (KIOM) Daegu, South Korea.
Front Pharmacol. 2016 Nov 30;7:460. doi: 10.3389/fphar.2016.00460. eCollection 2016.
Influenza causes respiratory infections and poses health risks to humans and animals; its effects are complicated by increasing resistance to existing anti-influenza viral agents. Therefore, novel therapeutic approaches against influenza virus infection are required. Psoraleae semen has been widely used in traditional medicine in Korea, Taiwan, China, and Japan for treating and preventing various diseases. In this study, we examined the anti-viral activities and mechanism of action of the water extract of Psoraleae semen (WPS) using RAW 264.7 and MDCK cells. We found that pre- and post-treatment with 100 μg/mL WPS markedly inhibited influenza A virus replication as assessed using a green fluorescent protein reporter virus, reduced viral protein expression (NS-1, PA, HA, PB-1, M1, and M2), and inhibited NA and HA activities. Mechanism studies revealed that WPS induced type I interferon cytokine secretion and subsequent stimulation of an anti-viral state in RAW 264.7 cells. Further, WPS exerted inhibitory effects on neuraminidase in influenza virus strains H1N1 and H3N2. Meanwhile, WPS exhibited inhibitory effects on hemagglutination in H3N2 but not in H1N1. Based on these results, WPS serves as an immunomodulator and inhibitor of influenza hemagglutinin and neuraminidase. Our results suggest that WPS is a promising source of novel anti-influenza drug candidates.
流感会引发呼吸道感染,并对人类和动物构成健康风险;由于对现有抗流感病毒药物的耐药性不断增加,其影响变得更加复杂。因此,需要新的抗流感病毒感染治疗方法。补骨脂种子在韩国、中国台湾、中国大陆和日本的传统医学中已被广泛用于治疗和预防各种疾病。在本研究中,我们使用RAW 264.7和MDCK细胞研究了补骨脂种子水提取物(WPS)的抗病毒活性及其作用机制。我们发现,用100μg/mL WPS进行预处理和后处理,使用绿色荧光蛋白报告病毒评估时,能显著抑制甲型流感病毒复制,降低病毒蛋白表达(NS-1、PA、HA、PB-1、M1和M2),并抑制NA和HA活性。机制研究表明,WPS可诱导RAW 264.7细胞分泌I型干扰素细胞因子,并随后刺激产生抗病毒状态。此外,WPS对甲型流感病毒H1N1和H3N2毒株的神经氨酸酶具有抑制作用。同时,WPS对H3N2的血凝反应有抑制作用,但对H1N1没有。基于这些结果,WPS可作为一种免疫调节剂以及流感血凝素和神经氨酸酶的抑制剂。我们的结果表明,WPS是新型抗流感药物候选物的一个有前景的来源。